JPRN-UMIN000027411已完成未知
Study of the role of VEGF-A and VEGF-A165b in pathophysiology of pulmonary hypertension - Study of the role of VEGF-A and VEGF-A165b in pathophysiology of pulmonary hypertension
agoya University0 个研究点目标入组 0 人开始时间: 2017年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
unpublishied
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1,Diagnosis of malignant tumor] 2,Diagnosis of myeloproliferative disorder 3,Diagnosis of inflammatory diseases 4,Patients already using pulmonary vasodilator (prostaglandin I 2 preparation, endothelin receptor antagonist, phosphodiesterase 5 inhibitor, soluble guanylate cyclase stimulant)
研究者
相似试验
已完成
不适用
Study of the role of VEGF-A and VEGF-A165b in pathophysiology of pulmonary hypertensioJPRN-UMIN000032723agoya Universiy50
已完成
不适用
Correlation of VEGF-A and Fluid Balance in Septic ShockSeptic ShockNCT04474431University Hospital, Rouen103
进行中（未招募）
不适用
VEGF, VEGFR1 and VEGFR2 expression in serous epithelial ovarian carcinoma, and its association to the efficacy of bevacizumab combined with paclitaxel and carboplatin as first line treatmentFIGO Stage III-IV serous epithelial ovarian carcinomaEUCTR2005-003209-10-FITampere University Hospital20
已完成
1 期
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD TrialNeovascular Age-related Macular DegenerationWet Age-related Macular DegenerationNCT03066258REGENXBIO Inc.42
已完成
不适用
Polymorphism Interaction to Predict Bevacizumab EfficacyMetastatic Breast CancerNCT01935102University of Pisa169